These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 37451146)
21. Discovery of small molecule acting as multitarget inhibitor of colorectal cancer by simultaneous blocking of the key COX-2, 5-LOX and PIM-1 kinase enzymes. El-Miligy MMM; Al-Kubeisi AK; El-Zemity SR; Nassra RA; Abu-Serie MM; Hazzaa AA Bioorg Chem; 2021 Oct; 115():105171. PubMed ID: 34303896 [TBL] [Abstract][Full Text] [Related]
22. Synthesis and biological evaluation of purine-pyrazole hybrids incorporating thiazole, thiazolidinone or rhodanine moiety as 15-LOX inhibitors endowed with anticancer and antioxidant potential. Afifi OS; Shaaban OG; Abd El Razik HA; Shams El-Dine SEA; Ashour FA; El-Tombary AA; Abu-Serie MM Bioorg Chem; 2019 Jun; 87():821-837. PubMed ID: 30999135 [TBL] [Abstract][Full Text] [Related]
23. Novel N-substituted indole Schiff bases as dual inhibitors of cyclooxygenase-2 and 5-lipoxygenase enzymes: Synthesis, biological activities in vitro and docking study. Lamie PF; Ali WAM; Bazgier V; Rárová L Eur J Med Chem; 2016 Nov; 123():803-813. PubMed ID: 27541263 [TBL] [Abstract][Full Text] [Related]
24. Synthesis of novel hybrids of pyrazole and coumarin as dual inhibitors of COX-2 and 5-LOX. Shen FQ; Wang ZC; Wu SY; Ren SZ; Man RJ; Wang BZ; Zhu HL Bioorg Med Chem Lett; 2017 Aug; 27(16):3653-3660. PubMed ID: 28720504 [TBL] [Abstract][Full Text] [Related]
25. Further insight into the dual COX-2 and 15-LOX anti-inflammatory activity of 1,3,4-thiadiazole-thiazolidinone hybrids: The contribution of the substituents at 5th positions is size dependent. Omar YM; Abdel-Moty SG; Abdu-Allah HHM Bioorg Chem; 2020 Apr; 97():103657. PubMed ID: 32086052 [TBL] [Abstract][Full Text] [Related]
38. Synthesis, inhibitory activity and in silico docking of dual COX/5-LOX inhibitors with quinone and resorcinol core. Sisa M; Dvorakova M; Temml V; Jarosova V; Vanek T; Landa P Eur J Med Chem; 2020 Oct; 204():112620. PubMed ID: 32738413 [TBL] [Abstract][Full Text] [Related]
39. Design, synthesis and evaluation of novel diaryl-1,5-diazoles derivatives bearing morpholine as potent dual COX-2/5-LOX inhibitors and antitumor agents. Li Z; Wang ZC; Li X; Abbas M; Wu SY; Ren SZ; Liu QX; Liu Y; Chen PW; Duan YT; Lv PC; Zhu HL Eur J Med Chem; 2019 May; 169():168-184. PubMed ID: 30877972 [TBL] [Abstract][Full Text] [Related]
40. Synthesis and structure-activity relationship studies of 1,3-diarylprop-2-yn-1-ones: dual inhibitors of cyclooxygenases and lipoxygenases. Rao PN; Chen QH; Knaus EE J Med Chem; 2006 Mar; 49(5):1668-83. PubMed ID: 16509583 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]